Glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus: a brief review

Glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus: a brief review

Manuel González-Ortiz 1, Esperanza Martínez-Abundis 1, Miriam Méndez-del Villar 2, Alejandra M. Ramírez-Rodríguez 2, Guillermo González-Gálvez 3, Karina G. Pérez-Rubio 1

1 Institute of Experimental and Clinical Therapeutics, Department of Physiology, Health Sciences University Center, University of Guadalajara, Guadalajara, Jal., Mexico; 2 Institute of Experimental and Clinical Therapeutics, Physiology Department, Health Science University Center, University of Guadalajara, Guadalajara, Jal., Mexico; 3 Servicio de Endocrinología, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Jal.; Instituto Jalisciense de Investigación en Diabetes y Obesidad S. C., Guadalajara, Jal., México

Manuel González-Ortiz, Esperanza Martínez-Abundis, Miriam Méndez-del Villar, Alejandra M. Ramírez-Rodríguez, Guillermo González-Gálvez, Karina G. Pérez-Rubio

La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.

*Correspondence: Alejandra M. Ramírez-Rodríguez, Email not available

Summary

Keywords:  Dulaglutide. Exenatide. Exenatide once-weekly. GLP-1 receptors agonist. Liraglutide. Lixisenatide. Type 2 diabetes mellitus.

Contents

DOI not available
    DOI not available